Financhill
Sell
40

SLND Quote, Financials, Valuation and Earnings

Last price:
$3.13
Seasonality move :
9.83%
Day range:
$3.12 - $3.23
52-week range:
$1.85 - $5.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.15x
P/B ratio:
1.03x
Volume:
35.8K
Avg. volume:
45.2K
1-year change:
-39.42%
Market cap:
$168.4M
Revenue:
$980.2M
EPS (TTM):
-$2.20
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.1B $1.3B $1.2B $1.2B $980.2M
Revenue Growth (YoY) 0.98% 20.91% -9.21% -0.09% -15.53%
 
Cost of Revenues $964.5M $1.2B $1B $1.1B $1B
Gross Profit $93.4M $114.2M $140.9M $35.8M -$63M
Gross Profit Margin 8.83% 8.93% 12.14% 3.09% -6.43%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $49.7M $58.1M $58.2M $67.2M $63.3M
Other Inc / (Exp) $3.9M $3.7M $2.1M $23.6M $3.4M
Operating Expenses $49.7M $58.1M $58.2M $67.2M $63.3M
Operating Income $43.7M $56.1M $82.7M -$31.4M -$126.3M
 
Net Interest Expenses $8.1M $7.3M $8.9M $19.5M $29.5M
EBT. Incl. Unusual Items $39.6M $52.5M $75.9M -$27.2M -$152.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $9.4M $10.9M $13.3M -$8.5M -$46.9M
Net Income to Company $30.2M $41.5M $62.7M -$18.7M -$105.5M
 
Minority Interest in Earnings $3.5M -$2.8M -$2.1M -$538K $163K
Net Income to Common Excl Extra Items $33.7M $38.7M $60.5M -$19.3M -$105.4M
 
Basic EPS (Cont. Ops) $0.76 $0.87 $1.36 -$0.41 -$2.19
Diluted EPS (Cont. Ops) $0.76 $0.87 $1.36 -$0.41 -$2.19
Weighted Average Basic Share $44.4M $44.4M $44.4M $47.1M $48.1M
Weighted Average Diluted Share $44.4M $44.4M $44.4M $47.1M $48.1M
 
EBITDA $87M $107.2M $130.5M $22.8M -$99.6M
EBIT $47.7M $59.7M $84.8M -$7.8M -$122.9M
 
Revenue (Reported) $1.1B $1.3B $1.2B $1.2B $980.2M
Operating Income (Reported) $43.7M $56.1M $82.7M -$31.4M -$126.3M
Operating Income (Adjusted) $47.7M $59.7M $84.8M -$7.8M -$122.9M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- $363.6M $294.8M $316.2M $267.3M
Revenue Growth (YoY) -- -- -18.93% 7.25% -15.48%
 
Cost of Revenues -- $324M $258.9M $295.1M $259.6M
Gross Profit -- $39.6M $35.9M $21.1M $7.7M
Gross Profit Margin -- 10.88% 12.16% 6.69% 2.87%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $16.1M $14.8M $19.9M $15.7M
Other Inc / (Exp) -- $1.4M $1.3M $54K $994K
Operating Expenses -- $16.1M $14.8M $19.9M $15.7M
Operating Income -- $23.5M $21M $1.2M -$8M
 
Net Interest Expenses -- $1.9M $2.6M $5.7M $9.6M
EBT. Incl. Unusual Items -- $22.9M $19.7M -$4.4M -$16.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $8.7M -$455K $2.9M -$14.1M
Net Income to Company -- -- $20.2M -$7.3M -$2.6M
 
Minority Interest in Earnings -- $679K -$634K $1.8M -$1.6M
Net Income to Common Excl Extra Items -- $14.8M $19.5M -$5.6M -$4.2M
 
Basic EPS (Cont. Ops) -- $0.33 $0.44 -$0.12 -$0.09
Diluted EPS (Cont. Ops) -- $0.33 $0.44 -$0.12 -$0.09
Weighted Average Basic Share -- $44.4M $44.4M $48M $48.2M
Weighted Average Diluted Share -- $44.4M $44.4M $48M $48.2M
 
EBITDA -- $37M $32.8M $7.1M -$675K
EBIT -- $24.8M $22.3M $1.3M -$7M
 
Revenue (Reported) -- $363.6M $294.8M $316.2M $267.3M
Operating Income (Reported) -- $23.5M $21M $1.2M -$8M
Operating Income (Adjusted) -- $24.8M $22.3M $1.3M -$7M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- $1.2B $1.2B $980.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $1B $1.1B $1B
Gross Profit -- -- $140.9M $35.8M -$63M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $58.2M $67.2M $63.3M
Other Inc / (Exp) -- $2.5M $2.1M $23.6M $3.4M
Operating Expenses -- -- $58.2M $67.2M $63.3M
Operating Income -- -- $82.7M -$31.4M -$126.3M
 
Net Interest Expenses -- $3.5M $8.9M $19.5M $29.5M
EBT. Incl. Unusual Items -- -- $75.9M -$27.2M -$152.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $13.3M -$8.5M -$46.9M
Net Income to Company -- -- $62.7M -$18.7M -$105.5M
 
Minority Interest in Earnings -- -$1.8M -$2.1M -$538K $163K
Net Income to Common Excl Extra Items -- -- $60.5M -$19.3M -$105.4M
 
Basic EPS (Cont. Ops) -- -- $1.36 -$0.42 -$2.20
Diluted EPS (Cont. Ops) -- -- $1.36 -$0.42 -$2.20
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- $130.5M $22.8M -$99.6M
EBIT -- -- $84.8M -$7.8M -$122.9M
 
Revenue (Reported) -- -- $1.2B $1.2B $980.2M
Operating Income (Reported) -- -- $82.7M -$31.4M -$126.3M
Operating Income (Adjusted) -- -- $84.8M -$7.8M -$122.9M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $679M $1.2B $1.2B $980.2M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $610M $1B $1.1B $1B --
Gross Profit $69M $140.9M $35.8M -$63M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $31.3M $58.2M $67.2M $63.3M --
Other Inc / (Exp) $2.5M $2.1M $23.6M $3.4M --
Operating Expenses $31.3M $58.2M $67.2M $63.3M --
Operating Income $37.7M $82.7M -$31.4M -$126.3M --
 
Net Interest Expenses $3.5M $8.9M $19.5M $29.5M --
EBT. Incl. Unusual Items $36.7M $75.9M -$27.2M -$152.4M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $11.1M $13.3M -$8.5M -$46.9M --
Net Income to Company -- $62.7M -$18.7M -$105.5M --
 
Minority Interest in Earnings -$1.8M -$2.1M -$538K $163K --
Net Income to Common Excl Extra Items $23.8M $60.5M -$19.3M -$105.4M --
 
Basic EPS (Cont. Ops) $0.54 $1.36 -$0.42 -$2.20 --
Diluted EPS (Cont. Ops) $0.54 $1.36 -$0.42 -$2.20 --
Weighted Average Basic Share $88.8M $177.6M $187.2M $192.3M --
Weighted Average Diluted Share $88.8M $177.6M $187.2M $192.3M --
 
EBITDA $64.1M $130.5M $22.8M -$99.6M --
EBIT $40.2M $84.8M -$7.8M -$122.9M --
 
Revenue (Reported) $679M $1.2B $1.2B $980.2M --
Operating Income (Reported) $37.7M $82.7M -$31.4M -$126.3M --
Operating Income (Adjusted) $40.2M $84.8M -$7.8M -$122.9M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $30.9M $63.3M $57.9M $49.2M $72.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $230.5M $237.7M $258.4M $304.4M $291.6M
Inventory -- -- $9.8M $5.5M $4.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $21.9M $23M $14.2M $14.6M $14.8M
Total Current Assets $805.1M $746.5M $867.3M $942.5M $881.7M
 
Property Plant And Equipment $204.6M $171.8M $131M $114.6M $131.2M
Long-Term Investments $100.3M $109.5M $119.6M $127.5M $132M
Goodwill $1.5M $1.5M $1.5M $1.5M $1.5M
Other Intangibles $5M $3.2M $2.2M $1.7M $1.2M
Other Long-Term Assets $4.1M $3.2M $3.7M $1.7M $1.5M
Total Assets $1.1B $1B $1.1B $1.2B $1.2B
 
Accounts Payable $148.8M $179.2M $160.1M $203.4M $225.3M
Accrued Expenses $120.1M $115.1M $121.6M $124.7M $91.5M
Current Portion Of Long-Term Debt $35.7M $41.3M $46.3M $48.5M $44.5M
Current Portion Of Capital Lease Obligations $18.3M $20M $16.6M $14.1M $10.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $607.7M $466.9M $476.1M $584M $621.1M
 
Long-Term Debt $162.7M $195.6M $227.3M $251.9M $255.6M
Capital Leases -- -- -- -- --
Total Liabilities $858M $733.4M $765.4M $940.5M $1B
 
Common Stock $260.8M $292.2M $352M $5K $5K
Other Common Equity Adj -$1.7M -$937K -$2.6M -$1.5M -$3.9M
Common Equity $233M $266.9M $325M $249.6M $163.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $3.6M $11.1M $10.4M $10.9M $11.8M
Total Equity $262.6M $302.4M $359.9M $260.6M $175.4M
 
Total Liabilities and Equity $1.1B $1B $1.1B $1.2B $1.2B
Cash and Short Terms $30.9M $63.3M $57.9M $49.2M $72.2M
Total Debt $198.3M $236.9M $273.6M $300.4M $300.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents -- $63.3M $57.9M $49.2M $72.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $237.7M $258.4M $304.4M $291.6M
Inventory -- -- $9.8M $5.5M $4.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $23M $14.2M $14.6M $14.8M
Total Current Assets -- $746.5M $867.3M $942.5M $881.7M
 
Property Plant And Equipment -- $171.8M $131M $114.6M $131.2M
Long-Term Investments -- $109.5M $119.6M $127.5M $132M
Goodwill -- $1.5M $1.5M $1.5M $1.5M
Other Intangibles -- $3.2M $2.2M $1.7M $1.2M
Other Long-Term Assets -- $3.2M $3.7M $1.7M $1.5M
Total Assets -- $1B $1.1B $1.2B $1.2B
 
Accounts Payable -- $179.2M $160.1M $203.4M $225.3M
Accrued Expenses -- $115.1M $121.6M $124.7M $91.5M
Current Portion Of Long-Term Debt -- $41.3M $46.3M $48.5M $44.5M
Current Portion Of Capital Lease Obligations -- $20M $16.6M $14.1M $10.1M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $466.9M $476.1M $584M $621.1M
 
Long-Term Debt -- $195.6M $227.3M $251.9M $255.6M
Capital Leases -- -- -- -- --
Total Liabilities -- $733.4M $765.4M $940.5M $1B
 
Common Stock -- $292.2M $352M $5K $5K
Other Common Equity Adj -- -$937K -$2.6M -$1.5M -$3.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $11.1M $10.4M $10.9M $11.8M
Total Equity -- $302.4M $359.9M $260.6M $175.4M
 
Total Liabilities and Equity -- $1B $1.1B $1.2B $1.2B
Cash and Short Terms -- $63.3M $57.9M $49.2M $72.2M
Total Debt -- $236.9M $273.6M $300.4M $300.2M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $30.2M $41.5M $62.7M -$18.7M -$105.5M
Depreciation & Amoritzation $39.4M $47.5M $45.7M $30.5M $23.3M
Stock-Based Compensation -- -- -- $891K $2M
Change in Accounts Receivable -$42.8M -$9.5M -$157.1M -$91.9M $80.6M
Change in Inventories -- -- -- -- --
Cash From Operations -$50.2M -$90.6M -$66.2M -$10.3M $1.9M
 
Capital Expenditures $31M $18.8M $4.8M $10.8M $7.4M
Cash Acquisitions -$16.2M -$587K -$664K -$540K --
Cash From Investing $195.8M -$8.5M $5.6M $4.5M $3.2M
 
Dividends Paid (Ex Special Dividend) -$6.4M -$2.6M -$2.5M -$110K --
Special Dividend Paid
Long-Term Debt Issued $91.4M $273.2M $75.3M $123.3M $173.1M
Long-Term Debt Repaid -$132.3M -$240.3M -$51.1M -$141.6M -$190.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$657K $355K -$1.6M $15.8M $35.9M
Cash From Financing -$48M $30.6M $20.1M -$2.6M $18.8M
 
Beginning Cash (CF) $81.7M $180.4M $111.2M $72M $63.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $97.7M -$68.5M -$40.5M -$8.4M $23.9M
Ending Cash (CF) $180.4M $111.2M $72M $63.8M $87.6M
 
Levered Free Cash Flow -$81.2M -$109.4M -$71M -$21.1M -$5.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- $20.2M -$7.3M -$2.6M
Depreciation & Amoritzation -- -- $10.5M $5.8M $6.4M
Stock-Based Compensation -- -- -- $407K $375K
Change in Accounts Receivable -- -- -$60.2M -$18M -$19.4M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- $4.7M $26.3M -$10.3M
 
Capital Expenditures -- -- $381K $3.4M $1.2M
Cash Acquisitions -- -- -$1M -$540K --
Cash From Investing -- -- $5.9M $5M $930K
 
Dividends Paid (Ex Special Dividend) -- -- -$901K -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $20.2M $4.9M $343K
Long-Term Debt Repaid -- -- -$13.6M -$18.1M -$9.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$1.2M -$1.1M -$664K
Cash From Financing -- -- $4.4M -$14.3M -$9.7M
 
Beginning Cash (CF) -- -- $57.5M $46.8M $106.7M
Foreign Exchange Rate Adjustment -- -- -$580K $69K -$146K
Additions / Reductions -- -- $15M $17M -$19M
Ending Cash (CF) -- -- $72M $63.8M $87.6M
 
Levered Free Cash Flow -- -- $4.4M $23M -$11.5M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -- -- $62.7M -$18.7M -$105.5M
Depreciation & Amoritzation -- -- $45.7M $30.5M $23.3M
Stock-Based Compensation -- -- -- $891K $2M
Change in Accounts Receivable -- -- -$157.1M -$91.9M $80.6M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$66.2M -$10.3M $1.9M
 
Capital Expenditures -- -- $4.8M $10.8M $7.4M
Cash Acquisitions -- -- -$664K -$540K --
Cash From Investing -- -- $5.6M $4.5M $3.2M
 
Dividends Paid (Ex Special Dividend) -- -- -$2.5M -$110K --
Special Dividend Paid
Long-Term Debt Issued -- -- $75.3M $123.3M $173.1M
Long-Term Debt Repaid -- -- -$51.1M -$141.6M -$190.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$1.6M $15.8M $35.9M
Cash From Financing -- -- $20.1M -$2.6M $18.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$40.5M -$8.4M $23.9M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -$71M -$21.1M -$5.5M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders -- $62.7M -$18.7M -$105.5M --
Depreciation & Amoritzation -- $45.7M $30.5M $23.3M --
Stock-Based Compensation -- -- $891K $2M --
Change in Accounts Receivable -- -$157.1M -$91.9M $80.6M --
Change in Inventories -- -- -- -- --
Cash From Operations -- -$66.2M -$10.3M $1.9M --
 
Capital Expenditures -- $4.8M $10.8M $7.4M --
Cash Acquisitions -- -$664K -$540K -- --
Cash From Investing -- $5.6M $4.5M $3.2M --
 
Dividends Paid (Ex Special Dividend) -- -$2.5M -$110K -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $75.3M $123.3M $173.1M --
Long-Term Debt Repaid -- -$51.1M -$141.6M -$190.3M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$1.6M $15.8M $35.9M --
Cash From Financing -- $20.1M -$2.6M $18.8M --
 
Beginning Cash (CF) -- $317.7M $216.4M $286.3M --
Foreign Exchange Rate Adjustment -- $1.3M $195K -$195K --
Additions / Reductions -- -$40.5M -$8.4M $23.9M --
Ending Cash (CF) -- $278.4M $208.2M $310M --
 
Levered Free Cash Flow -- -$71M -$21.1M -$5.5M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Why Did Signet Jewelers Stock Go Up So Much?
Why Did Signet Jewelers Stock Go Up So Much?

Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…

Why Did HealthEquity Stock Fall So Much?
Why Did HealthEquity Stock Fall So Much?

HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
85
SLNO alert for Mar 29

Soleno Therapeutics [SLNO] is up 6.8% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock